K. Kotsa

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
K Kotsa, K. D. Kotsa, Kalliopi Kotsa, K. Kotsa, Kalliopi D Kotsa
Publication record
252 papers · 4,931 citations · H-index 31

PAPERS

Clinical Guidelines for the Diagnosis and Management of generalized and partial lipodystrophies: A Position statement endorsed by the Hellenic Endocrine Society.
20260 citationsauthor #4
One-Hour Post-Load Glucose Is Associated with Multisystem Complications in People Living with Obesity.
20260 citationsauthor #5
Factors Associated with GLP-1 Receptor Agonist Use in Patients with Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Retrospective Propensity-Score Matched Analysis.
20260 citationsauthor #5
Assessment of attitudes toward weight loss pharmacotherapy among Greek patients living with obesity: a questionnaire-based study.
20260 citationsauthor #8
Presepsin as a biomarker of coronary artery disease in type 2 diabetes along the immune-inflammatory continuum.
20260 citationsauthor #8
Nutritional Interventions in Type 1 Diabetes: Boosting Residual GLP-1 Responses-Is It an Option?
20260 citationsauthor #4
Obesity, but Not Overweight, Is Associated with Increased Presepsin Levels in Infection-Free Individuals: An Exploratory Study
20259 citationsauthor #14
Duration of vitamin D supplementation modulates the association between cardiovascular disease and high-sensitivity C-reactive protein across body mass index strata.
20251 citationsauthor #8
A Narrative Review of the Odyssey of Thyroid Cancer Diagnosis: Can 99mTc-SESTAMIBI Molecular Imaging Replace Fine Needle Aspiration Biopsy?
20250 citationsauthor #9
Evaluating Guideline Alignment by Analyzing Patient Profiles of Elderly People with Type 2 Diabetes and Chronic Kidney Disease Treated or Not with SGLT2 Inhibitors
20253 citationsauthor #9
Interleukin-6-Related Inflammatory Burden in Type 1 Diabetes: Evidence for Elevation with Suboptimal Glycemic Control
20253 citationsauthor #12
Circulating Beta-Defensin 2 Levels Correlate with Conventional Inflammatory Markers in Infection-Free Individuals with Overweight and Obesity: An Exploratory Study
20253 citationsauthor #17
The effects of SGLT2 inhibitors and GLP-1 receptor agonists on the triglyceride to HDL cholesterol ratio and the triglyceride-glucose index in patients with type 2 diabetes.
20252 citationsauthor #7
Metabolomics Insights into the Benefits of SGLT2 Inhibitors in Type 2 Diabetes
20251 citationsauthor #4
Dual target, dual benefit: real-world effects of SGLT2 inhibitors and GLP-1 receptor agonists on the FIB-4 score in people with type 2 diabetes mellitus.
20250 citationsauthor #4
Rationale for the establishment of a national integrated adult type 1 diabetes clinical center in a Mediterranean country: real-world experience and associated costs
20250 citationsauthor #4
Definition, Classification, Diagnosis, and Management of an Emerging Threat: Cardio-Renal-Metabolic Syndrome
20252 citationsauthor #5
Preliminary Study on Circulating REG3α and Its Associations with Vitamin D Supplementation and Inflammatory Biomarkers in Adults with Overweight and Obesity
20250 citationsauthor #14
Presepsin: An Emerging Biomarker in the Management of Cardiometabolic Disorders
20256 citationsauthor #11
Clinical Inertia in SGLT2 Inhibitor Use Among Elderly Patients with Type 2 Diabetes and Chronic Kidney Disease: A Comparison of Regional and University Hospital Practice
20253 citationsauthor #6
Exploring the Role of Presepsin in the Prediction of Atrial Fibrillation Recurrence: Results from the PLACEBO Study
20250 citationsauthor #4
Strong Association Between MiRNA Gene Variants and Type 2 Diabetes Mellitus in a Caucasian Population
20250 citationsauthor #11
Association between clinical and laboratory factors and response to sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes: a retrospective observational study
20242 citationsauthor #4
Hypoglycemic Drugs in Patients with Diabetes Mellitus and Heart Failure: A Narrative Review
20247 citationsauthor #10
2014-LB: Association between Variants in Genes Involved in the Metabolism of Uric Acid and the Risk of Type 2 Diabetes
20240 citationsauthor #11
Clinical and laboratory factors associated with response to therapy with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus
20240 citationsauthor #3
Circulating MicroRNAs Related to Arterial Stiffness in Adults with HIV Infection
20242 citationsauthor #6
Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas
20247 citationsauthor #9
Precision medicine in type 2 diabetes mellitus: Unraveling the role of TCF7L2, CTRB1/2, and GLP-1R genetic variants in response to treatment with glucagon-like peptide-1 receptor agonists
20240 citationsauthor #9
Above the Clouds with Diabetes: From Pathophysiological Considerations to Practical Recommendations for Safe Flights
20240 citationsauthor #7
Presepsin Levels in Infection-Free Subjects with Diabetes Mellitus: An Exploratory Study
20247 citationsauthor #14
Obesity and overweight are common among hospitalized patients and are associated with specific causes of admission to an internal medicine department: a cross-sectional study
20245 citationsauthor #5
Vitamin D Supplementation: Shedding Light on the Role of the Sunshine Vitamin in the Prevention and Management of Type 2 Diabetes and Its Complications
202423 citationsauthor #6
The Mediterranean diet, but not time-restricted eating, mediates the effects of nesfatin on beta cell function among overweight, metabolically healthy individuals
20241 citationsauthor #7
Metabolic Dysfunction-Associated Steatotic Liver Disease and Polycystic Ovary Syndrome: A Complex Interplay
202420 citationsauthor #7
The Effect of Activity Tracking Apps on Physical Activity and Glycemic Control in People with Prediabetes Compared to Normoglycemic Individuals: A Pilot Study
20241 citationsauthor #8
Association between variants in TCF7L2, CTRB1/2, and GLP-1R genes and response to therapy with glucagon-like peptide-1 receptor agonists
20249 citationsauthor #8
Epidemiological, Pathophysiological, and Clinical Considerations on the Interplay between Thyroid Disorders and Type 2 Diabetes Mellitus
202316 citationsauthor #3
Teplizumab: promises and challenges of a recently approved monoclonal antibody for the prevention of type 1 diabetes or preservation of residual beta cell function
20237 citationsauthor #4
Infection with the human immunodeficiency virus is characterized by a downregulation of the inverse relationship between irisin and parathyroid hormone independently of vitamin D status
20230 citationsauthor #14
Changes in the Global Epidemiology of Type 1 Diabetes in an Evolving Landscape of Environmental Factors: Causes, Challenges, and Opportunities
202353 citationsauthor #3
Different patterns of changes in free 25-hydroxyvitamin D concentrations during intermittent fasting among meat eaters and non-meat eaters and correlations with amino acid intake
20237 citationsauthor #9
Secondary diabetes mellitus in acromegaly
202329 citationsauthor #4
Weight Loss Versus Glycemic Control as the Primary Treatment Target in Newly Diagnosed Type 2 Diabetes: Why Choose When You Can Have Both?
20238 citationsauthor #5
Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential.
202314 citationsauthor #5
The Current Place of DPP4 Inhibitors in the Evolving Landscape of Type 2 Diabetes Management: Is It Time to Bid Adieu?
20239 citationsauthor #4
A Mediterranean Eating Pattern Combining Energy and Time-Restricted Eating Improves Vaspin and Omentin Concentrations Compared to Intermittent Fasting in Overweight Individuals
202310 citationsauthor #9
“You are my sunshine, my only sunshine”: maternal vitamin D status and supplementation in pregnancy and their effect on neonatal and childhood outcomes
202311 citationsauthor #8
Mediterranean diet, type 2 diabetes prevention and healthy ageing: do we need more evidence?
20233 citationsauthor #3
GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations and Practical Recommendations for Safe and Effective Use
202318 citationsauthor #8
The effects of sodium-glucose cotransporter 2 inhibitors beyond the cardio-renal-metabolic spectrum: will gliflozins have a different fate than statins?
20235 citationsauthor #4
Variations in plasma free 25-hydroxyvitamin D concentrations during intermittent fasting are independently correlated with amino acid intake among meat and non-meat eaters
20230 citationsauthor #10
Management of Type 2 Diabetes in Acute Coronary Syndromes: Current State and Future Perspectives.
20233 citationsauthor #5
Down regulation of the inverse relationship between parathyroid hormone and irisin in male vitamin D-sufficient HIV patients
20231 citationsauthor #13
Changes in dietary intake of aspartic acid during and after intermittent fasting correlate with an improvement in fasting glucose in overweight individuals
20235 citationsauthor #5
Potential Role of Ultrafast-acting Insulin Analogues in the Treatment of Diabetic Ketoacidosis
20224 citationsauthor #3
Clinical and Genetic Predictors of Glycemic Control and Weight Loss Response to Liraglutide in Patients with Type 2 Diabetes
202220 citationsauthor #11
Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs – The CAPISCO International Expert Panel
20227 citationsauthor #4
Could the Majority of the Greek and Cypriot Population Be Vitamin D Deficient?
202217 citationsauthor #2
565-P: Vitamin D Supplementation Improves Anxiety and Depression Status in Elderly People with Prediabetes: An Open-Label 12-Month Randomized Controlled Study
20220 citationsauthor #15
Translation of the Pasieka’s Parathyroid Assessment of Symptoms Questionnaire (PAS-Q) for Use in the Greek Population
20224 citationsauthor #8
How Far beyond Diabetes Can the Benefits of Glucagon-like Peptide-1 Receptor Agonists Go? A Review of the Evidence on Their Effects on Hepatocellular Carcinoma
202232 citationsauthor #3
Toward a new model for the management of type 2 diabetes: The mountain is there and there is no other option than to climb it.
20227 citationsauthor #3
The effect of vitamin D supplementation on glycemic status of elderly people with prediabetes: a 12-month open-label, randomized-controlled study
20227 citationsauthor #11
The effect of vitamin D on people with prediabetes
20220 citationsauthor #1
Association between clinical and genetic factors and glycemic and weight loss response to liraglutide in patients with type 2 diabetes
20220 citationsauthor #11
Remission of type 2 diabetes depends on prompt comprehensive lifestyle changes upon diagnosis: How can this "Road to Damascus" experience be supported?
20227 citationsauthor #2
From Skepticism to Hope: The Evolving Concept of the Initiation and Use of Sodium-Glucose Cotransporter 2 Inhibitors in Hospitalized Patients
202219 citationsauthor #7
The importance of sleep quality, quantity, and chronotype in the management of diabetes: Is it time to wake up?
20224 citationsauthor #4
The effects of sodium-glucose cotransporter 2 inhibitors on hepatocellular carcinoma: From molecular mechanisms to potential clinical implications.
202229 citationsauthor #3
COVID-19 and sulfonylureas: A reminder of the pleiotropic actions of an old class of drugs just before their swansong
20224 citationsauthor #4
Remission as an Emerging Therapeutic Target in Type 2 Diabetes in the Era of New Glucose-Lowering Agents: Benefits, Challenges, and Treatment Approaches
202222 citationsauthor #6
Can sodium-glucose cotransporter 2 inhibitors 'spin the thread of life'?
202210 citationsauthor #3
Antiatherosclerotic Effects of Sodium-Glucose Cotransporter 2 Inhibitors: An Underrecognized Piece of the Big Puzzle?
20227 citationsauthor #4
A Horse, a Jockey, and a Therapeutic Dilemma: Choosing the Best Option for a Patient with Diabetes and Coronary Artery Disease
20229 citationsauthor #3
Dual sodium-glucose cotransporter (SGLT) 1/2 versus pure SGLT2 inhibitors: two distinct drug categories or one class with multiple faces?
20228 citationsauthor #4
Vitamin D Alleviates Anxiety and Depression in Elderly People with Prediabetes: A Randomized Controlled Study
202214 citationsauthor #12
Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care
202297 citationsauthor #5
Intestinal SGLT1 as a therapeutic target in COVID‐19‐related diabetes: A “two‐edged sword” hypothesis
202112 citationsauthor #4
THE EFFECT OF DAPAGLIFLOZIN ON 24-HOUR BLOOD PRESSURE AND ARTERIAL STIFFNESS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS: A DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL
20211 citationsauthor #4
Type 2 diabetes management in people aged over seventy-five years: targets and treatment strategies.
202115 citationsauthor #3
Upregulation of Irisin and Vitamin D-Binding Protein Concentrations by Increasing Maternal 25-Hydrovitamin D Concentrations in Combination with Specific Genotypes of Vitamin D-Binding Protein Polymorphisms
20214 citationsauthor #9
Vitamin D equilibrium affects sex-specific changes in lipid concentrations during Christian Orthodox fasting.
20213 citationsauthor #11
The impact of age on quality of life and frailty outcomes after parathyroidectomy in patients with primary hyperparathyroidism
20218 citationsauthor #6
New Antidiabetic Therapies: A Paradigm Shift in Type 2 Diabetes Management.
20211 citationsauthor #3
Sex-specific variations in lipid concentrations following a low-fat diet are mediated by vitamin D status: a 12-week prospective dietary intervention study among Christian Orthodox fasters
20210 citationsauthor #11
PDB23 Investigating Internistsâ€™ Endocrinologistsâ€™ and Paediatriciansâ€™ Attitudes in Regards to the VALUE of Innovative Diabetes Mellitus Self-Monitoring Technologies in Greece
20210 citationsauthor #15
Implementation of Christian Orthodox fasting improves plasma adiponectin concentrations compared with time-restricted eating in overweight premenopausal women
202120 citationsauthor #9
Oxidative Stress Genes in Diabetes Mellitus Type 2: Association with Diabetic Kidney Disease
202125 citationsauthor #8
Sodium-glucose co-transporter 2 inhibitors in COVID-19: meeting at the crossroads between heart, diabetes and infectious diseases
202125 citationsauthor #4
MO642 DAPAGLIFLOZIN HAS NO IMPACT ON SHORT-TERM BLOOD PRESSURE VARIABILITY IN PATIENTS WITH TYPE-2 DIABETES MELLITUS
20210 citationsauthor #6
Non-insulin agents for the management of gestational diabetes: lack of evidence versus lack of action
20210 citationsauthor #4
MO642DAPAGLIFLOZIN HAS NO IMPACT ON SHORT-TERM BLOOD PRESSURE VARIABILITY IN PATIENTS WITH TYPE-2 DIABETES MELLITUS
20210 citationsauthor #6
Treatment options following metformin in primary prevention populations with type 2 diabetes: which is the right road to take?
202111 citationsauthor #4
Variants in clock genes could be associated with lower risk of type 2 diabetes in an elderly Greek population.
20215 citationsauthor #14
Sodium-Glucose Co-transporter 2 Inhibitors Versus Metformin as the First-Line Treatment for Type 2 Diabetes: Is It Time for a Revolution?
20216 citationsauthor #4
Insights Into the Results of Sotagliflozin Cardiovascular Outcome Trials: Is Dual Inhibition the Cherry on the Cake of Cardiorenal Protection?
202125 citationsauthor #5
Effects of Christian Orthodox Fasting Versus Time-Restricted Eating on Plasma Irisin Concentrations Among Overweight Metabolically Healthy Individuals
202117 citationsauthor #8
The role of autoimmunity in the pathophysiology of type 2 diabetes: Looking at the other side of the moon
202117 citationsauthor #5
Looking deeper into the findings of DARE-19: Failure or an open door to future success?
202110 citationsauthor #5

TIMELINE

1995 0 citations

1996 17 citations

1997 335 citations

2008 18 citations

2009 208 citations

2010 52 citations

2011 137 citations

2012 11 citations

2013 54 citations

2014 5 citations

2015 45 citations

2016 339 citations

2017 464 citations

2018 1,723 citations

2019 296 citations

2020 355 citations

2021 242 citations

2022 328 citations

2023 199 citations

2024 84 citations

2025 33 citations

2026 0 citations

Unknown 0 citations

K. Kotsa

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT